Search
Harmaline
go.drugbank.com/drugs/DB13875ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome7-Nitroindazole
go.drugbank.com/drugs/DB02207ExperimentalCategories: Compounds used in a research, industrial, or household settingMK-0354
go.drugbank.com/drugs/DB05939InvestigationalMK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. … It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.
REP8839
go.drugbank.com/drugs/DB05224ExperimentalREP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
Prolectin-M
go.drugbank.com/drugs/DB16521InvestigationalProlectin-M is a (1-6)-alpha-D-mannopyranose[L31338] and acts as an antagonist of galectin.
AVX-001
go.drugbank.com/drugs/DB19194InvestigationalSubjects With AK). … AVX-001 is under investigation in clinical trial NCT05164393 (Phase I/iia Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult
Esaxerenone
go.drugbank.com/drugs/DB15207InvestigationalEsaxerenone is under investigation in clinical trial NCT02722265 (Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
Insulin peglispro
go.drugbank.com/drugs/DB11567InvestigationalCategories: Compounds used in a research, industrial, or household settingDiethyl ether
go.drugbank.com/drugs/DB13598InvestigationalCategories: Compounds used in a research, industrial, or household settingPsoralen
go.drugbank.com/drugs/DB18665InvestigationalCategories: Compounds used in a research, industrial, or household setting, Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates